To further advance our understanding, it is crucial to explore the shared molecular pathways involved in both WIRS‐induced GFAP loss and SNS‐induced restoration of GFAP expression, as they may reveal key therapeutic targets for depression and stress‐related disorders. Here, GFAP is linked to depressive symptom measurement.